BiotechTube
Home/Bicara Therapeutics/Fortunato (Fred) C. O. (Chuck) Olson
F(

Fortunato (Fred) C. O. (Chuck) Olson

Chief Scientific Officer

Bicara Therapeutics

Therapeutic Areas

Oncology

Bicara Therapeutics Pipeline

DrugIndicationPhase
BCA101Recurrent/Metastatic Cutaneous Squamous Cell Carcinoma (cSCC)Phase 1b/2

Leadership Team at Bicara Therapeutics

CM
Claire Mazur
Chief Executive Officer
DJ
David J. Donabedian
Chief Technology Officer
MJ
Mark J. Charette
Chief Business Officer
DS
David S. Grayzel
Chief Medical Officer
J(
James (Jim) P. Boylan
Chief Financial Officer
View full Bicara Therapeutics profile